Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.68 -5.33%
EPS Growth %: -138.7%
Financial Fact:
Product sales: 96.7M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -138.7%
Financial Fact:
Product sales: 96.7M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Signet shares jump on Q2 profit beat, raised annual guidance
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
